The AAE Steering Committee has defined an overall strategy and clear agenda spanning 2018-2021
that align AAE’s work with these growing concerns. Through this, we will strengthen our response
to the epidemic, maintain our commitments and provide a framework in which we can prioritise our
actions. It is AAE’s duty to keep HIV/AIDS, TB and viral hepatitis as priorities on EU, national and
regional health agendas. AAE will build the advocacy capacity of civil society organisations, in order to mitigate the obstacles that limit universal access to prevention, treatment, care and affordable medicines.